Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Estrogen Therapy on Ghrelin and Leptin in Overweight/Obese Women With Surgical Menopause
TCTR20210831004Phase 0Not yet recruiting
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0 trial of DehydraTECH-estrogen in Surgical Menopause, obesity and Overweight, sponsored by Ratchadaphiseksomphot Endowment Fund. Primary endpoints: Change in ghrelin levels and Change in leptin levels. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
DehydraTECH-estrogen
03
Conditions
Surgical MenopauseobesityOverweight
Beyond the preview
Go deeper on TCTR20210831004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210831004.